Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-26-000169

Chief Executive Officer gave up 10,955 shares (to pay taxes)

  • Chief Executive Officer acquired 21,736 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-15 Exercise or conversion : show line 1 in the form +21,736 93,849 D
2026-08-15 Shares withheld for taxes : show line 2 in the form −10,955 $72.40 $793,142 82,894 D

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2026-08-15 Returned to the company : show line 3 in the form Performance Stock Options (Right to Buy) −22,044 1,837 D
2026-08-15 Returned to the company : show line 4 in the form Performance Stock Options (Right to Buy) −23,949 1,996 D
2026-08-15 Exercise or conversion : show line 5 in the form Performance Restricted Stock Units −683 8,190 D
2026-08-15 Returned to the company : show line 6 in the form Performance Restricted Stock Units −8,190 0 D
2026-08-15 Exercise or conversion : show line 7 in the form Performance Restricted Stock Units −725 8,698 D
2026-08-15 Returned to the company : show line 8 in the form Performance Restricted Stock Units −8,698 0 D
2026-08-15 Exercise or conversion : show line 9 in the form Restricted Stock Units −8,543 8,544 D
2026-08-15 Exercise or conversion : show line 10 in the form Restricted Stock Units −11,785 23,569 D
Loading xslF345X06/form4a.xml…